Articles written by Matthew Perrone

Sorted by date  Results 1 - 25 of 135



ALS drug will be pulled from US market after study showed patients didn't benefit

WASHINGTON (AP) — The maker of a drug for Lou Gehrig's disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn't help patients with the deadly neurological condition. Amylyx P...

 

Lawsuit seeks to force ban on menthol cigarettes after months of delays by Biden administration

WASHINGTON (AP) — Anti-smoking groups sued the U.S. government Tuesday over a long-awaited ban on menthol cigarettes, which has been idling at the White House for months. The lawsuit is the latest effort to force the government to ban menthols, w...

 

AI chatbots are here to help with your mental health, despite limited evidence they work

WASHINGTON (AP) — Download the mental health chatbot Earkick and you're greeted by a bandana-wearing panda who could easily fit into a kids' cartoon. Start talking or typing about anxiety and the app generates the kind of comforting, sympathetic s...

 

First over-the-counter birth control pill in US begins shipping to stores

WASHINGTON (AP) — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin. Manufacturer Perrigo said M...

 

As investors pile into psychedelics, idealism gives way to pharma economics

Money is pouring into the fledgling psychedelic medicine industry, with dozens of startup companies vying to be among the first to sell mind-expanding drugs for depression, addiction and other mental health conditions. While psychedelics are still...

 

Florida can import prescription drugs from Canada, US regulators say

WASHINGTON (AP) — The Food and Drug Administration on Friday cleared the way for Florida's first-in-the-nation plan to import prescription drugs from Canada, a long-sought approach to accessing cheaper medications that follows decades of frustration...

 

After recalls and infections, experts say safer eyedrops will require new FDA powers

WASHINGTON (AP) — When you buy eyedrops at a U.S. store, you might assume you're getting a product made in a clean, well-maintained factory that's passed muster with health regulators. But repeated recalls involving over-the-counter drops are d...

 

Mind-altering ketamine becomes latest pain treatment, despite little research or regulation

WASHINGTON (AP) — As U.S. doctors scale back their use of opioid painkillers, a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a trendy psychedelic therapy. Prescriptions for ketamine have s...

 

First over-the-counter birth control pill gets FDA approval

WASHINGTON (AP) — Federal regulators on Thursday approved the nation's first over-the-counter birth control pill in a landmark decision that will soon allow American women and girls to obtain contraceptive medication as easily as they buy aspirin a...

 

FDA warns stores to stop selling Elf Bar, the top disposable e-cigarette in the US

WASHINGTON (AP) — The Food and Drug Administration on Thursday said it has sent warning letters to dozens of retailers selling fruit- and candy-flavored disposable e-cigarettes, including the current best-selling brand, Elf Bar. It's the latest a...

 

Abortion clinics in 3 states sue to protect pill access

Abortion providers in three states filed a lawsuit Monday aimed at preserving access to the abortion pill mifepristone, even as the drug is threatened by a separate Texas lawsuit winding its way through U.S. court system. The lawsuit, filed in U.S....

 

What does 1870s Comstock Act have to do with abortion pills?

WASHINGTON (AP) — A 19th century "anti-vice" law is at the center of a new court ruling that threatens access to the leading abortion drug in the U.S. Dormant for a half-century, the Comstock Act has been revived by anti-abortion groups and c...

 

Access to abortion pill in limbo after competing rulings

AUSTIN, Texas (AP) — Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday following conflicting court rulings over the legality of the abortion medication mifepristone that has been widely available for m...

 

Eyedrops maker couldn't ensure factory was sterile, FDA says

WASHINGTON (AP) — The manufacturer of eyedrops recently linked to deaths and injuries lacked measures to assure sterility at its factory in India, according to U.S. health inspectors. Food and Drug Administration officials uncovered about a dozen pro...

 

Long-used US abortion pill under threat in Texas lawsuit

AMARILLO, Texas (AP) — A federal judge in Texas raised questions Wednesday about a Christian group's effort to overturn federal regulators' decades-old approval of a leading abortion drug, in a case that could threaten the country's most common m...

 

Sleep apnea device recall drags on, stoking frustration

WASHINGTON (AP) — A massive recall of millions of sleep apnea machines has stoked anger and frustration among patients, and U.S. officials are weighing unprecedented legal action to speed a replacement effort that is set to drag into next year. S...

 

Over-the-counter hearing aids expected this fall in US

WASHINGTON (AP) — Millions of Americans will be able to buy hearing aids without a prescription later this fall, under a long-awaited rule finalized Tuesday. The Food and Drug Administration said the new regulation cuts red tape by creating a new c...

 

US will stretch monkeypox vaccine supply with smaller doses

WASHINGTON (AP) — U.S. health officials on Tuesday authorized a plan to stretch the nation's limited supply of monkeypox vaccine by giving people just one-fifth the usual dose, citing research suggesting that the reduced amount is about as e...

 

Medication abortion is common; here's how it works.

Medication abortions became the preferred method for ending pregnancy in the U.S. even before the Supreme Court overturned Roe v. Wade. These involve taking two prescription medicines days apart — at home or in a clinic. Abortion procedures are an in... Full story

 

Parents hunting for baby formula as shortage spans US

WASHINGTON (AP) — Parents across the U.S. are scrambling to find baby formula because supply disruptions and a massive safety recall have swept many leading brands off store shelves. Months of spot shortages at pharmacies and supermarkets have b...

 

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to a rare but serious risk of blood clots. The Food and Drug Administration said the shot should only be given to adults who canno...

 

US opens second COVID boosters to 50 and up, others at risk

Americans 50 and older can get a second COVID-19 booster if it's been at least four months since their last vaccination, a chance at extra protection for the most vulnerable in case the coronavirus rebounds. The Food and Drug Administration on...

 

FDA skeptical of benefits from experimental ALS drug

WASHINGTON (AP) — Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, after months of lobbying by patient advocates urging approval. The drug f...

 

Pfizer asks FDA to allow COVID-19 vaccine for kids under 5

WASHINGTON (AP) — Pfizer on Tuesday asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March. In an e...

 

FDA: Merck COVID pill effective, experts will review safety

Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy. The Food and Drug...

 

Page Down

Our Family of Publications Includes:

Arc
Newsgram

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2024